Houston, TX—Hard times are getting even tougher for small oncology practices, said Leonard Natelson, Chief Executive Officer, Hematology/Oncology Associates, Rockland, NY, at the Second Annual Conference of the Association for Value-Based Cancer Care.
Before 2005, the Centers for Medicare & Medicaid Services (CMS) reimbursed physicians for drugs administered in their offices at a percentage of the average wholesale price. In 2005, however, the payment basis was changed to a percentage of a newly created measure, the average sales price. This change resulted in a significant change to the bottom line for all physician practices that administered chemotherapy and other infused drugs.
Read Now
Stay up to date with urology news & updates by subscribing to receive the free UPM print publications or e‑Newsletters.